G3BPs tether the TSC complex to lysosomes and suppress mTORC1 signaling
What this study shows
Adds a physical brake upstream of mTORC1. G3BP1 and G3BP2, known until then as core stress-granule proteins, also sit on the cytoplasmic face of the lysosome and are what holds the TSC complex there; without them TSC cannot reach its target and mTORC1 becomes over-responsive to amino acids and insulin. Loss of G3BP1 reproduces TSC-like hyperactivity phenotypes: faster mTORC1-driven motility in breast cancer cells, with low G3BP1 correlating with worse patient outcome, and disturbed neuronal development in zebrafish. Relevant to the Atlas because it is a lysosomal tethering step that the canonical Rheb/TSC diagram does not show.
Abstract
ShowHide
Ras GTPase-activating protein-binding proteins 1 and 2 (G3BP1 and G3BP2, respectively) are widely recognized as core components of stress granules (SGs). We report that G3BPs reside at the cytoplasmic surface of lysosomes. They act in a non-redundant manner to anchor the tuberous sclerosis complex (TSC) protein complex to lysosomes and suppress activation of the metabolic master regulator mechanistic target of rapamycin complex 1 (mTORC1) by amino acids and insulin. Like the TSC complex, G3BP1 deficiency elicits phenotypes related to mTORC1 hyperactivity.
Read the full abstract on PubMed →At a glance
ShowHide
| Evidence type | M Molecular — cells, biochemistry, structure Marked M because it is molecular or in-vitro work (model: Human and mouse cells; breast cancer patient data; zebrafish) rather than a whole-organism health-outcome study. That is often exactly where causal biology gets established -- the code says which system the finding was shown in, and nothing about how good the work is. |
| Study type | 5 - Mechanistic / In Vitro |
| Model system | Human and mouse cells; breast cancer patient data; zebrafish |
| Journal | Cell |
| Year | 2021 |
| Peer reviewed | Yes |
| Record last updated | 2026-10-01 |
| Source | DOI 10.1016/j.cell.2020.12.024 · PMID 33497611 |
Where this study fits
How this study connects to the pathway map, open questions, people and other studies in the Atlas.
People in the Atlas
-
First author of the study showing that G3BP proteins anchor the TSC complex to lysosomes, a physical brake on mTORC1; earlier co-author on the dynamic insulin–mTOR network model.
-
Senior author of three Atlas studies that treat mTOR signalling as a dynamic network: TSC-independent mTORC2 activation, concurrent AMPK and mTOR activation by amino acids, and G3BP tethering of TSC to lysosomes.
-
Head of the Freiburg department that hosted the Thedieck group during the mTOR network modelling work; co-author on the dynamic mTOR model and the G3BP–TSC study.
-
Cell biologist who studied how lipid metabolism and the lysosome feed into mTORC1, first at the University of Liège and then at the Max Planck Institute for Biology of Ageing in Cologne
-
First author of the study showing why mTORC1 stays switched on in senescent cells, and co-author on G3BP–TSC and senescence-mitophagy work; her own lab studies how nutrient sensing breaks down in ageing cells.
More: 42 other authors
-
Showed as a postdoc in Aurelio Teleman's lab that starvation and other stresses pull TSC2 to the lysosome to switch mTORC1 off. His group, at the Max Planck Institute for Biology of Ageing in Cologne from 2017 and at ERIBA in Groningen since 2025, studies how cells sense nutrients and stress through mTORC1 and how this changes with age
-
Cell biologist who studied how mTORC1 senses nutrients in Aurelio Teleman's group at the German Cancer Research Center, including the finding that glutamine is sensed through the kinase GCN2, and who now works at the Institute of Neuropathology in Aachen
-
Cell biologist in Lukas Huber's group in Innsbruck who solved the crystal structure of the Ragulator (LAMTOR) complex, the lysosomal platform on which mTORC1 is switched on
-
Cell biologist and Junior Group Leader at the University of Innsbruck who studies how mTOR balances growth signalling and metabolism when cells are under stress, trained in Kathrin Thedieck's systems-biology group
-
Cell biologist who studied the p14-MP1 scaffold on late endosomes, a complex later recognised as part of Ragulator (LAMTOR), the lysosomal platform that holds mTORC1 in place
-
Showed that where lysosomes sit inside the cell tunes mTORC1 activity to nutrient supply. His Newcastle lab found that senescent cells can no longer switch mTORC1 off when nutrients or growth factors are withdrawn, and studies how autophagy and mitophagy decline with age
-
Clinical geneticist who led the consortium that identified the TSC2 gene and led trials of mTOR inhibitors in tuberous sclerosis, including the TRON trial of everolimus for cognition.
-
Uses fruit-fly genetics and human cells to study how growth signalling through TOR controls cell and body size. His lab showed that starvation and other stresses move TSC2 to the lysosome to switch mTORC1 off
No profile yet: Rehbein U, Cadena Sandoval M, De Meulemeester AS, Berdel B, Bockwoldt M, Chowdhury SR, von Deimling A, Heiland I, Holzwarth B, Jaworski J, Kedra M, Kern K, Kopach A, van 't Land-Kuper I, Macias M, Nellist M, Palm W, Pusch S, Ramos Pittol JM, Reil M, Reintjes A, Reuter F, Scheldeman C, Siekierska A, Stefan E, Thomas LE, Torres-Quesada O, Trump S, West HD, de Witte P, Woltering S, Yordanov TE, Zmorzynska J, Opitz CA
Related studies
- M Regulation of TORC1 in response to amino acid starvation via lysosomal recruitment of TSC2
DEM2014 · 2014 · Shares: Lysosome, TSC1/TSC2, mTORC1
- H
- A A bi-steric mTORC1-selective inhibitor overcomes drug resistance in breast cancer
MEN2023 · 2023 · Shares: Breast cancer, mTORC1
- H Everolimus in postmenopausal hormone-receptor-positive advanced breast cancer (BOLERO-2)
BAS2012 · 2012 · Shares: Breast cancer, mTORC1
- M Collagen I promotes cancer cell survival via amino acid import and mTORC1/S6 activation
NAZ2026 · 2026 · Shares: Breast cancer, mTORC1
More related studies
- M
- M Spatial and functional separation of mTORC1 signalling in response to different amino acid sources
FER2024 · 2024 · Shares: Lysosome, mTORC1
- R The molecular basis of nutrient sensing and signalling by mTORC1 in metabolism regulation and disease
GOU2023 · 2023 · Shares: Lysosome, mTORC1
- M A Rag GTPase dimer code defines the regulation of mTORC1 by amino acids
GOL2022 · 2022 · Shares: Lysosome, mTORC1
- M NUFIP1 is a ribosome receptor for starvation-induced ribophagy
WYA2018 · 2018 · Shares: Lysosome, mTORC1
- R Amino Acid Sensing by mTORC1: Intracellular Transporters Mark the Spot
GOB2016 · 2016 · Shares: Lysosome, mTORC1
- M Dynamics of mTORC1 activation in response to amino acids
MAN2016 · 2016 · Shares: Lysosome, mTORC1
- M Dynamic Visualization of mTORC1 Activity in Living Cells
ZHO2015 · 2015 · Shares: Lysosome, mTORC1
Topics
Extracted findings
These fields were extracted from the paper with AI assistance and have not been checked against the source. Read them as a pointer into the paper, not as curated claims; where they disagree with the curated summary above, the curated summary stands.
| Intervention | G3BP1/G3BP2 knockout/knockdown; G3bp1 inhibition in zebrafish |
| Target | G3BP1/2 tethering of the TSC complex to lysosomes; mTORC1 |
| Model | Human and mouse cells; zebrafish; breast cancer patient data (correlative) |
| Effect | Loss of G3BPs releases TSC from lysosomes and makes mTORC1 hyperactive to amino acids and insulin. |
Thank you. Your answer was counted anonymously.